Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Elutia Inc. (ELUT) vs Talis Biomedical Corporation (TLIS)

Elutia Inc. and Talis Biomedical Corporation are both Medical Devices companies. Talis Biomedical Corporation is the larger, with a market value of $46.3M against $36.8M — 1.3× the size. Talis Biomedical Corporation has negative trailing earnings, so its P/E is not meaningful; Elutia Inc. trades at 0.7×. Elutia Inc. grew revenue faster over the last twelve months: 69.0% against −65.2%. Elutia Inc. has the higher net margin (488.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Talis Biomedical Corporation leads on 9 and Elutia Inc. on 7.

Valuation

Metric ELUT TLIS Medical Devices median
P/E 0.67 n/m 22.18
P/S 2.99 5.23 2.70
P/B 2.30 0.11 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m 1.01 11.78
EV/Sales 3.50 (55.30) 2.38
Earnings yield 150.00% (986.62%) (8.22%)
Free cash flow yield (126.92%) (775.19%) (7.80%)

Profitability

Metric ELUT TLIS Medical Devices median
Gross margin 57.76% 97.27% 56.01%
Operating margin (214.85%) 0.00% (15.03%)
Net margin 488.15% 0.00% (20.40%)
Free cash flow margin (379.26%) 0.00% (7.24%)
Return on equity (454.01%) (70.48%) (15.32%)
Return on assets 152.89% (52.13%) (19.72%)
Return on invested capital 0.00% 0.00% (10.33%)

Growth

Metric ELUT TLIS Medical Devices median
Revenue growth (TTM) 69.03% (65.21%) 8.80%
EPS growth (last fiscal year) 146.77% 46.33% —
Revenue growth, 5-year CAGR (22.04%) (2.24%) 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELUT TLIS Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 1.77 7.76 2.50
Net debt to EBITDA 1.51 1.16 0.49

Dividend

Metric ELUT TLIS Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric ELUT TLIS Medical Devices median
Market cap 36.76m 46.27m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack